Evidence map›Paper›PMID 42018371›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2026

Toward a Peritoneal Dialysis-First Policy in the United Kingdom and Europe: A Phenotype-Based Analysis of Survival and System-Level Implications.

Hatem Ali, Tibor Fülöp, Anna Maria Casula, Andre Paola Ortega Alban, Samar Abd ElHafeez, Rizwan Hamer

Abstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hatem AliRenal Department, University Hospitals of Wales, United Kingdom.ORCID 0000-0002-3141-7015
Tibor FülöpDivison of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-3346-7040
Anna Maria CasulaStatistical Department, UK Kidney Registry, United Kingdom.
Andre Paola Ortega AlbanStatistical Department, UK Kidney Registry, United Kingdom.ORCID 0000-0002-0555-1237
Samar Abd ElHafeezEpidemiology Department, High Institute of Public Health, Alexandria University, Alexandria, Egypt.ORCID 0000-0002-3250-2780
Rizwan HamerRenal Department, University Hospitals of Coventry and Warwickshire, United Kingdom.ORCID 0000-0003-3750-3130

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

key pointsIn a contemporary UK cohort of 96,809 patients, peritoneal dialysis was associated with lower mortality than hemodialysis across all phenotypes. The magnitude of this association varied by phenotype and attenuated with increasing age. Phenotype-based analyses may support more individualized dialysis modality selection and inform system-level policy decisions.

backgroundWhether peritoneal dialysis (PD) is associated with lower mortality than hemodialysis in contemporary practice remains debated, particularly across heterogeneous patient populations and in the presence of competing transplantation. We examined modality-associated mortality differences across data-driven phenotypes of incident dialysis patients in the United Kingdom using a competing-risks framework.

methodsWe analyzed 96,809 adults initiating dialysis in the United Kingdom Renal Registry between 2007 and 2021. Unsupervised k-prototypes clustering was used to derive phenotypes based on age, sex, ethnicity, primary kidney disease, hemoglobin, serum albumin, and transplant-listing status. Mortality during the dialysis phase before transplantation was analyzed using competing-risks methods, treating kidney transplantation as a competing event. Cumulative incidence of death at 1 and 5 years was modeled using jack-knife pseudo-value regression with complementary log-log links, adjusting for demographic and clinical covariates. Dialysis modality (hemodialysis versus PD) was the primary exposure, with stratified analyses performed within each phenotype. A complementary competing-risks analysis examined time to transplantation.

resultsAmong incident patients, 24% initiated PD and 76% hemodialysis. Three reproducible phenotypes were identified, differing primarily by age, hemoglobin and albumin levels, and transplant-listing status. Across the overall cohort, hemodialysis was associated with a higher cumulative incidence of death before transplantation at both 1 year (subdistribution hazard ratio [sHR], 1.85; 95% confidence interval [CI], 1.75 to 1.96) and 5 years (sHR, 1.47; 95% CI, 1.43 to 1.51). In stratified analyses, hemodialysis was associated with higher mortality across all phenotypes. At 1 year, adjusted sHRs ranged from 1.55 (95% CI, 1.44 to 1.68) to 2.29 (95% CI, 1.87 to 2.80) across clusters. At 5 years, the association persisted but attenuated with increasing age, with adjusted sHRs of 2.42 (95% CI, 2.23 to 2.63) in the youngest phenotype, 1.55 (95% CI, 1.48 to 1.61) in the intermediate phenotype, and 1.14 (95% CI, 1.11 to 1.19) in the oldest phenotype. In complementary analyses, time to transplantation did not differ significantly across phenotypes after adjustment.

conclusionsIn contemporary UK practice, hemodialysis was associated with higher mortality during the dialysis phase compared with PD across distinct patient phenotypes, with time-dependent variation in effect magnitude. These registry-based associations support consideration of phenotype-informed modality selection while acknowledging the potential for residual confounding and the influence of health system context.

Indexed as

Kidney Failure, ChronicPeritoneal DialysisRenal DialysisAdultAgedEuropeFemaleHumansKidney TransplantationMaleMiddle AgedPhenotypeRegistriesRisk FactorsUnited Kingdomdialysis

Identifiers

PMID42018371
PMCPMC13379130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.